Middlebrook Pharmaceuticals, Inc.
SEC CIK 1161924 · MBRKQ · last insider filing 2010-12-07
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Blyth Lord James | Director | filed 2008–2009 |
| Cavanaugh James H | Director | filed 2006–2009 |
| Werner Harold R | Director | filed 2006–2009 |
| Pate William | Director | filed 2008–2009 |
| Douglas R Gordon | Director | filed 2006–2009 |
| Vogelbaum Martin | Director | filed 2007–2009 |
| Dugan Richard W | Director | filed 2006–2009 |
| Sotir Mark R | Director | filed 2008–2009 |
| Thievon John | Director · President and CEO | filed 2008–2008 |
| Hockmeyer Wayne T | Director | filed 2006–2008 |
| Rudnic Edward M | Director · President and CEO | filed 2006–2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cole Brad | SVP, General Counsel | filed 2008–2010 |
| Miller Timothy L | SVP, Sales Ops & Admin | filed 2008–2009 |
| Treacy Donald J | SVP, Devel & Manf Oper | filed 2008–2009 |
| Koos Frank | SVP, Sales & Business Develop | filed 2008–2008 |
| Burnside Beth A | SVP, Reg Affairs, Comp & Strat | filed 2008–2008 |
| Clausen Susan P | SVP, Clinical Res & Med Aff | filed 2008–2008 |
| Becker David Paul | EVP & CFO | filed 2008–2008 |
| Low Robert C | Vice President & CFO | filed 2006–2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.